Clinical Partnerships Ampersand Health operates in behavioural health and real world data across oncology, immunology, and inflammation, collaborating with HCPs and researchers at over 30 institutions in the US and UK. This presents an opportunity to position patient journey analytics and predictive health insights as value-add for hospital networks, academic centers, and contract research organizations seeking real-world evidence.

Dermatology Growth Recent launches of disease-specific apps such as My Derm and My Arthritis indicate a focused product expansion into dermatology and inflammatory conditions. This creates cross-sell opportunities for additional skin-related cohorts, digital therapeutics, and remote monitoring solutions within ambulatory and specialty clinics.

Sizable Market Fit Revenue appears in the low to mid multi-million range with lean headcount (11-50 employees), suggesting a scalable platform with potential for enterprise partnerships. Target mid-market hospitals, health systems, and specialty networks looking to enhance long-term condition management through real world data analytics.

Strategic Alliances Active collaboration history with industry players and ventures, including a partnership with PharmStars and projects with UCB, demonstrates openness to co-development and sponsored research. Leverage these relationships to propose joint ventures, pilot programs, or research grants that validate real world evidence propositions.

Expansion & Data Ongoing platform expansion across inflammatory conditions and predictive monitoring capabilities signals readiness for data-enabled care pathways. Upsell opportunities exist in integrating with hospital EHRs, expanding patient cohorts, and delivering actionable insights to clinicians and researchers to improve remission and treatment outcomes.